CAS: 18623-44-4 - 4-[5-(3,4-DIMETHOXY-BENZYLIDENE)-4-OXO-2-THIOXO-THIAZOLIDIN-3-YL]-BUTYRIC ACID
Formel:C16H16NO5S2
InChl:InChI=1/C16H17NO5S2/c1-21-11-6-5-10(8-12(11)22-2)9-13-15(20)17(16(23)24-13)7-3-4-14(18)19/h5-6,8-9H,3-4,7H2,1-2H3,(H,18,19)/p-1/b13-9-
- Synonyme:
- 3-Thiazolidinebutanoic acid, 5-[(3,4-dimethoxyphenyl)methylene]-4-oxo-2-thioxo-, (5Z)-
- 4-[(5Z)-5-(3,4-Dimethoxybenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]butanoic acid
- 4-[(5Z)-5-(3,4-dimethoxybenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]butanoate
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
4-{5-[(3,4-Dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}butanoic acid REF: 3D-TAA62344CAS: 18623-44-4 | Min. 95% | Nachfragen | Fr 27 Dez 24 | |
iCRT-5 REF: TM-T27582CAS: 18623-44-4 | 99.68% | 62,00 €~721,00 € | Do 02 Jan 25 |
4-{5-[(3,4-Dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}butanoic acid
CAS:18623-44-4
4-{5-[(3,4-Dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}butanoic acid is a potent inhibitor of the insulin receptor signaling pathway. It has been …
Formel:
C16H17NO5S2
Reinheit:
Min. 95%
Molekulargewicht:
367.4 g/mol
Ref: 3D-TAA62344
10mg | 297,00 € | ||
100mg | 1.111,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 27. Dezember 2024
iCRT-5
CAS:18623-44-4
iCRT-5 is a potent inhibitor of the Wnt pathway. iCRT-5 has antiproliferative activity and can …
Formel:
C16H17NO5S2
Reinheit:
99.68%
Farbe und Form:
Solid
Molekulargewicht:
367.44
Ref: TM-T27582
1mg | 62,00 € | ||
5mg | 132,00 € | ||
10mg | 204,00 € | ||
25mg | 344,00 € | ||
50mg | 506,00 € | ||
100mg | 721,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 2. Januar 2025